IP Library Granted Patent US 8,515,553
Granted Patent B2
US 8,515,553 · App. 12/110,384 · Granted Aug 20, 2013

Methods and apparatus for predictively controlling the temperature of a coolant delivered to a treatment device

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,515,553
App. No.
12/110,384
Granted
Aug 20, 2013
Kind
B2
Abstract

Apparatus and methods for predictively controlling the temperature of a coolant delivered to a treatment apparatus configured to non-invasively treat a patient's tissue with doses of electromagnetic energy. The treatment apparatus includes a closed-loop cooling system connected with an energy delivery device used to deliver the electromagnetic energy to the patient's tissue. Coolant is pumped from a reservoir to the energy delivery device in the closed-loop cooling system. The control temperature of the coolant in the reservoir is adjusted based upon the specific room air temperature. This predictive adjustment promotes better control over the coolant temperature at the energy delivery device by lessening the effects of heat gain in transit from the reservoir to the energy delivery device.

Claims (38)

1. A method for treating tissue beneath a skin surface with electromagnetic energy, the method comprising:

pumping a fluid from a reservoir to an energy delivery device;

circulating the fluid through the energy delivery device;

returning the fluid from the energy delivery device to the reservoir;

measuring a value of a room air temperature proximate to at least one of the energy delivery device or the reservoir;

adjusting a control temperature of the fluid in the reservoir based upon the measured value of the room air temperature; and

delivering the electromagnetic energy from the energy delivery device to the tissue.

2. The method of claim 1 wherein adjusting the control temperature of the fluid in the reservoir further comprises:

based upon the value of the room air temperature and a desired fluid temperature at the energy delivery device, retrieving a numerical adjustment to the control temperature from a lookup table stored in a memory.

3. The method of claim 2 further comprising:

storing the numerical adjustment as an entry in the lookup table in the memory.

4. The method of claim 2 wherein the lookup table contains a data array correlating a change in the control temperature between the reservoir and the energy delivery device with the room air temperature, and further comprising:

storing the data array of the lookup table in the memory.

5. The method of claim 4 wherein the memory is included in a system controller configured to control operation of the energy delivery device, and further comprising:

measuring the change in the control temperature and a desired fluid temperature at the energy delivery device as a function of the room air temperature; and

generating the lookup table with the system controller from the measured change at each room air temperature.

6. The method of claim 1 wherein operation of the energy delivery device is controlled by a system controller, and adjusting the control temperature of the fluid in the reservoir further comprises:

calculating with the system controller a numerical adjustment to the control temperature using a mathematical relationship relating the control temperature to the room air temperature.

7. The method of claim 6 further comprising:

measuring a change in the control temperature as a function of the room air temperature; and

generating with the system controller the mathematical relationship from the measured change in the control temperature at each different room air temperature.

8. The method of claim 1 further comprising:

re-measuring the value of the room air temperature proximate to at least one of the energy delivery device or the reservoir; and

adjusting the control temperature of the fluid in the reservoir based upon the re-measured value of the room air temperature.

9. The method of claim 1 wherein adjusting the control temperature of the fluid in the reservoir further comprises:

cooling the fluid in the reservoir such that the control temperature is below the desired temperature at the energy delivery device.

10. The method of claim 9 wherein adjusting the control temperature of the fluid in the reservoir further comprises:

determining an adjustment to the control temperature based upon the value of the room air temperature;

communicating the adjustment to a temperature controller for a coldplate; and

circulating the fluid from the reservoir to the coldplate configured to cool the fluid sufficiently to maintain the fluid in the reservoir at the adjusted control temperature.

11. The method of claim 1 wherein the electromagnetic energy heats the tissue, and further comprising:

contacting the skin surface with a portion of the energy delivery device while delivering the electromagnetic energy to heat the tissue; and

cooling a region of the heated tissue beneath the contacted skin surface with the fluid circulating through the energy delivery device.

12. The method of claim 1 wherein the electromagnetic energy heats the tissue, and further comprising:

contacting the skin surface with a portion of the energy delivery device while delivering the electromagnetic energy to heat the tissue in a non-invasive manner; and

cooling a region of the heated tissue beneath the contacted skin surface with the fluid circulating through the energy delivery device.

13. The method of claim 1 wherein the electromagnetic energy is delivered to the tissue by capacitively coupling and heat the tissue, and further comprising:

cooling a region of the heated tissue beneath the skin surface with the fluid circulating through the energy delivery device.

Assignments (1)
RELEASE OF SECURITY INTEREST Recorded Apr 8, 2025
From: BARCLAYS BANK PLC, AS COLLATERAL AGENT
To: SOLTA MEDICAL, INC.; PRECISION DERMATOLOGY, INC.; BAUSCH HEALTH IRELAND LIMITED (F/K/A/ VALEANT PHARMACEUTICALS IRELAND LIMITED); SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD; SANTARUS, INC.; MEDICIS PHARMACEUTICAL CORPORATION; HUMAX PHARMACEUTICAL S.A.; SOLTA MEDICAL IRELAND LIMITED; BAUSCH & LOMB MEXICO, S.A. DE C.V.; BAUSCH+LOMB OPS B.V.; BAUSCH HEALTH AMERICAS, INC.; BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH HOLDCO LIMITED; BAUSCH HEALTH MAGYARORSZAG KFT (A/K/A BAUSCH HEALTH HUNGARY LLC); BAUSCH HEALTH POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA (F/K/A VALEANT PHARMA POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA); BAUSCH HEALTH US, LLC; BAUSCH HEALTH, CANADA INC. / SANTE BAUSCH, CANADA INC.; ICN POLFA RZESZOW SPOLKA AKCYJNA (A/K/A ICN POLFA RZESZOW S.A.); ORAPHARMA, INC.; PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA SPOLKA AKCYJNA (A/K/A PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA S.A.); SOLTA MEDICAL DUTCH HOLDINGS B.V.; V-BAC HOLDING CORP.; VRX HOLDCO LLC; 1261229 B.C. LTD.; 1530065 B.C. LTD.
Reel/Frame 070778/0199 →